The article discusses the Global Pandemic Treaty, officially known as the WHO Pandemic Agreement, which is currently being negotiated. The central claim is that the treaty, aimed at preventing and responding to future pandemics, is significantly weakened by compromises and concessions made to various national interests, particularly those of the United States and European countries. These concessions have undermined the treaty’s initial goals of global health equity and preparedness.
A key point of contention is the access to and sharing of pathogens and data. Wealthy nations, particularly those with powerful pharmaceutical industries, have resisted binding commitments to share intellectual property and technology related to vaccines and treatments. This resistance is viewed as prioritizing corporate profits over equitable access for developing nations.
The article highlights the lack of robust enforcement mechanisms and penalties for non-compliance as a major flaw. The agreement is described as being filled with qualifiers and non-binding language, essentially making it toothless in ensuring adherence to its principles. Developing countries feel that the treaty does not adequately address their concerns regarding equitable access to resources and technology during pandemics.
The article concludes that the current draft of the Pandemic Agreement is a watered-down version of its original intent, primarily serving the interests of powerful nations and pharmaceutical corporations, rather than promoting genuine global health security and equity. The compromises have rendered the treaty ineffective in addressing the systemic inequalities that were exposed during the COVID-19 pandemic.
find the original article here: https://www.wsws.org/en/articles/2025/06/02/qmqb-j02.html